Thursday, October 25, 2012
Drugmaker Boehringer settles marketing claim for $95 million: U.S.
WASHINGTON (Reuters) - Boehringer Ingelheim Pharmaceuticals Inc agreed to pay $95 million to U.S. government agencies to settle civil allegations that it illegally marketed drugs for unapproved uses, the U.S. Justice Department said on Thursday. 
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment